Agriculture

  • Notice of Reopening of Public Comment Period--Proposed Directives for National Best Management Practices (BMPs) for Water Quality Protection on National Forest System (NFS) Lands

    AGENCY: Forest Service, USDA.

    ACTION: Notice of reopening of public comment period.


    SUMMARY: The Forest Service is reopening the public comment period for the proposed directive regarding best management practices (BMPs) for water quality protection on National Forest System (NFS) lands for an additional 30 days. The original notice called for comments to be submitted by July 7, 2014.

    DATES: Comments must be received, in writing, on or before August 21, 2014.

    ADDRESSES: Submit comments electronically by following the instructions at the federal eRulemaking portal at http://www.regulation.gov. Comments may also be submitted by electronic mail to fsm2500@fs.fed.us or by mail to BMP Directive Comments, USDA Forest Service, Attn: Michael Eberle--WFWARP, 201 14th St. SW., Washington, DC 20250. If comments are submitted electronically, duplicate comments should not be sent by mail. Please confine comments to issues pertinent to the proposed directive, explain the reasons for any recommended changes, and, where possible, reference the specific section and wording being addressed. All comments, including names and addresses when provided, will be placed in the record and will be made available to the public for review and copying. The public may inspect the comments received on the proposed directive at the USDA Forest Service Headquarters, located in the Yates Federal Building at 201 14th Street SW., Washington, DC, on regular business days between 8:30 a.m. and 4:30 p.m. Those wishing to inspect the comments are encouraged to call ahead at (202) 205-1205 to facilitate entry into the building.

    FOR FURTHER INFORMATION CONTACT: Michael Eberle, Watershed, Fish, Wildlife, Air and Rare Plants Staff at (202) 205-1093. Individuals who use telecommunication devices for the deaf (TDD) may call the Federal Information Relay Service at (800) 877-8339 between 8:00 a.m. and 8:00 p.m., Eastern Daylight Time, Monday through Friday.

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-22/html/2014-17163.htm

  • Environmental Protection Agency

  • Good Neighbor Environmental Board

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Request for Nominations to the Good Neighbor Environmental Board.


    SUMMARY: The Environmental Protection Agency (EPA) invites nominations from a diverse range of qualified candidates to be considered for appointment to its Good Neighbor Environmental Board (GNEB). Vacancies are expected to be filled by March 9, 2015. Sources in addition to this Federal Register Notice may also be utilized in the solicitation of nominees.

    Background: GNEB is a federal advisory committee chartered under the Federal Advisory Committee Act (FACA), Public Law 92-463. GNEB was created in 1992 by the Enterprise for the Americas Initiative Act, Public Law 102-532, 7 U.S.C. 5404. Implementing authority was delegated to the Administrator of EPA under Executive Order 12916. The GNEB is charged by statute with submitting an annual report to the President on the need for implementation of environmental and infrastructure projects within the states of the United States contiguous to Mexico. The statute calls for the GNEB to have representatives from U.S. Government agencies; the governments of the states of Arizona, California, New Mexico and Texas; and tribal and private organizations with experience in environmental and infrastructure issues along the U.S./Mexico Border. Members are appointed by the EPA Administrator for two year terms with the possibility of reappointment. The GNEB meets approximately three times annually either in person or via video/ teleconference. The average workload for committee members is approximately 10 to 15 hours per month. Members serve on the committees in a voluntary capacity. Although we are unable to offer compensation or an honorarium, members may receive travel and per diem allowances, according to applicable federal travel regulations. The EPA is seeking nominations from a variety of nongovernmental interests along the U.S.- Mexico border from the private sector, including representatives from business, academia, environmental groups, health groups, ranching and grazing, energy, financial, and other relevant sectors. EPA values and welcomes diversity. In an effort to obtain nominations of diverse candidates, EPA encourages nominations of women and men of all racial and ethnic groups.

    The following criteria will be used to evaluate nominees:

    Background and experiences that would help members contribute to the diversity of perspectives on the committee (e.g., geographic, economic, social, cultural, educational, and other considerations).

    Representative of a sector or group that helps to shape border-region environmental policy or representatives of a group that is affected by border region environmental policy.

    Has extensive professional knowledge and experience with the particular issues that the GNEB examines (i.e. environmental and infrastructure issues along the U.S.-Mexico border), including the bi- national dimension of these issues.

    Bring senior level experience that will fill a need of the GNEB in bringing a new and relevant dimension to its deliberations.

    Possesses a demonstrated ability to work in a consensus building process with a wide range of representatives from diverse constituencies.

    Ability to contribute approximately 10 to 15 hours per month to the GNEB's activities, including face-to-face meetings, conference calls and participation in the development of the GNEB's annual report to the President and comment letters.

    Nominees may self-nominate by submitting a resume describing their professional and educational qualifications, including current business address, email and daytime telephone number.

    All nominees must demonstrate the potential for active and constructive involvement in the GNEB's work.

    If you are interested in serving on GNEB, we will need the following items to process your nomination package:

    Nominations must include a brief statement of interest, resume, curriculum vitae, or a short biography (no more than two paragraphs) describing your professional and educational qualifications, including a list of relevant activities and any current or previous service on advisory committees. The statement of interest, resume, curriculum vitae, or short biography should include the candidate's name, name and address of current organization, position title, email address, and daytime telephone number(s). In preparing your statement of interest, please describe how your background, knowledge, and experience will bring value to the work of the committee, and how these qualifications would contribute to the overall diversity of the GNEB. Also, be sure to describe any previous involvement with the Agency through employment, grant funding and/or contracting sources.

    Candidates from the academic sector must also provide a letter of recommendation authorizing the nominee to represent their institution.

    Please be advised that federal registered lobbyists are not permitted to serve on federal advisory boards.

    ADDRESSES: Submit nominations to Ann-Marie Gantner, Acting Designated Federal Officer, Office of Diversity, Advisory Committee Management and Outreach (1601M), 1200 Pennsylvania Avenue NW., Washington, DC 20460. You may also email nominations with the subject line COMMITTEE RESUME 2014 to gantner.ann-marie@epa.gov.

    FOR FURTHER INFORMATION CONTACT: Ann-Marie Gantner, Acting Designated Federal Officer, U.S. EPA, telephone 202-564-4330, fax: 202-564-8129.

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-23/html/2014-17241.htm

  • Health and Human Services

  • Advancing the Use of Biomarkers and Pharmacogenomics; Notice of Public Meeting; Request for Comments

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notice of public meeting; request for comments.


    The Food and Drug Administration (FDA or the Agency) is announcing a public meeting to discuss current scientific and regulatory approaches to biomarker development, acceptance, and utility in drug and biologic (hereafter referred to as therapeutic product) development programs. The purpose of the public meeting is to initiate constructive discussion and information sharing on the advancement of biomarker science in the context of therapeutic product development among relevant stakeholders. Specifically, the meeting will focus on identifying challenges for biomarker applications in early- and late- phase clinical trials and emerging best practices for successful biomarker-based programs, including codevelopment of in vitro diagnostic devices and use of biomarkers as outcome measures in clinical trials. FDA is conducting this meeting in collaboration with Brookings Institution. This meeting satisfies an FDA commitment that is part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V).

    Date and Time: The meeting will be held on September 5, 2014, from 9 a.m. to 5 p.m.

    Location: The public meeting will be held at the Washington Plaza Hotel, 10 Thomas Circle NW., Washington, DC 20005. For additional travel and hotel information, please refer to http://www.brookings.edu/events/2014/09/05-biomarkers-pharmaceutical-FDA. (FDA has verified the Web site addresses throughout this notice, but FDA is not responsible for subsequent changes to the Web sites after this document publishes in the Federal Register).

    Contacts: Padmaja Mummaneni, Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave., Bldg. 51, Rm. 2164, Silver Spring, MD 20993, 301-796-2027, email: padmaja.mummaneni@fda.hhs.gov; or Stephen Ripley, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993, 240-402- 7911, email: stephen.ripley@fda.hhs.gov.

    Registration: The meeting venue has limited seating. Individuals who wish to attend the public meeting must register on or before August 5, 2014, by visiting http://events.SignUp4.com/PDUFAPublic2014. Early registration is recommended. When registering, please provide the following information: Name, title, company or organization (if applicable), postal address, telephone number, and email address. Registration is free and will be on a first-come, first-served basis. However, Brookings may limit the number of participants from each organization based on space limitations. Onsite registration on the day of the meeting by Brookings will be based on space availability.

    If you need special accommodations because of disability, please contact Joanna Klatzman at the Brookings Institution (email: jklatzman@brookings.edu) at least 7 days before the meeting.

    Streaming Webcast of the Public Meeting: A live Webcast of this meeting will be viewable at http://www.brookings.edu/events/2014/09/05-biomarkers-pharmaceutical-FDA on the day of the meeting. A video record of the meeting will be available at the same Web address for 1 year.

    Comments: Regardless of attendance at the public meeting, interested persons may submit electronic comments to http://www.regulations.gov or written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. It is only necessary to send one set of comments. Identify all comments with the corresponding docket number found in brackets in the heading of this document. To ensure consideration, submit comments by November 5, 2014. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

    Transcripts: Please be advised that as soon as a transcript is available, it will be accessible at http://www.regulations.gov. It may be viewed at the Division of Dockets Management (see Comments). A transcript will also be available in either hard copy or on CD-ROM, after submission of a Freedom of Information request. Written requests are to be sent to Division of Freedom of Information (ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr, Element Bldg., Rockville, MD 20857.

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-22/html/2014-17090.htm

  • Announcement of Requirements and Registration for "Stories of Basic Science to Medical Advances'' Challenge

    DEPARTMENT OF HEALTH AND HUMAN SERVICES

    National Institutes of Health


    SUMMARY: The National Institute of General Medical Sciences (NIGMS), one of the components of the National Institutes of Health (NIH), announces a challenge titled "Stories of Basic Science to Medical Advances.'' This Challenge aims to track medical advances stemming from NIGMS-supported basic science.

    DATES: Submission Period: July 21, 2014--October 20, 2014. Judging Period: October 21, 2014--November 20, 2014. Winners announced: 14 days after judging is complete.

    FOR FURTHER INFORMATION CONTACT: Darren Sledjeski, Ph.D. 301-594-0943, nigms_challenges@mail.nih.gov.

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-23/html/2014-17330.htm

  • Public Meeting of the Presidential Commission for the Study of Bioethical Issues

    AGENCY: Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

    ACTION: Notice of meeting.


    SUMMARY: The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its eighteenth meeting on August 20, 2014. At this meeting, the Commission will discuss the BRAIN Initiative and ongoing work in neuroscience.

    DATES: The meeting will take place Wednesday, August 20, 2014, from 9 a.m. to approximately 5 p.m.

    ADDRESSES: Hamilton Crowne Plaza Hotel, 1001 14th St. NW., Washington, DC 20005.

    FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional information may be obtained at www.bioethics.gov.

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-25/html/2014-17563.htm

  • National Science Foundation

  • Sunshine Act Meetings; National Science Board

    NATIONAL SCIENCE FOUNDATION


    The National Science Board's Committee on Strategy and Budget (CSB), pursuant to NSF regulations (45 CFR part 614), the National Science Foundation Act, as amended (42 U.S.C. 1862n-5), and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business, as follows:

    DATE AND TIME: Tuesday, July 29, 2014, 1:00-2:00 p.m. EDT.

    SUBJECT MATTER: Committee Chairman's remarks; consideration of NSF's FY 2016 budget proposal.

    STATUS: Closed.

    This meeting will be held by teleconference. A public listening line will be available. Members of the public must contact the Board Office (call 703-292-7000 or send an email message to nationalsciencebrd@nsf.gov) at least 24 hours prior to the teleconference for the public listening number. Please refer to the National Science Board Web site www.nsf.gov/nsb for additional information and schedule updates (time, place, subject matter or status of meeting) which may be found at http://www.nsf.gov/nsb/notices/. Point of contact for this meeting is Jacqueline Meszaros (jmeszaro@nsf.gov).

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-24/html/2014-17503.htm

  • Office of Science and Technology Policy

  • National Nanotechnology Coordination Office

    AGENCY: Office of Science and Technology Policy.

    ACTION: Notice of Public Webinar.


    SUMMARY: The National Nanotechnology Coordination Office (NNCO), on behalf of the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the Committee on Technology,

    National Science and Technology Council (NSTC), will hold a public webinar on Thursday, July 31, 2014. The purpose of this webinar is to provide a forum to answer questions related to the Federal Government's "Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative (NNI) 2011 Environmental, Health, and Safety Research Strategy.'' Discussion during the webinar will focus on the research activities undertaken by NNI agencies to advance the current state of the science as highlighted in the progress review. Representative research activities as provided in the Progress Review will be discussed in the context of the 2011 NNI EHS Research Strategy's six core research areas: Nanomaterial Measurement Infrastructure, Human Exposure Assessment, Human Health, the Environment, Risk Assessment and Risk Management Methods, and Informatics and Modeling.

    DATES: The public webinar will be held on Thursday, July 31, 2014, from 12:00 p.m. to 13:00 p.m.

    ADDRESSES: For information about the webinar, please visit www.nano.gov.

    Submitting Questions: Questions on the progress review document may be submitted to webinar@nnco.nano.gov beginning at noon (EDT) Thursday, July 24, 2014, through the close of the webinar at 13:00 p.m. on Thursday, July 31, 2014.

    The Webinar: During the question-and-answer segment of the webinar, submitted questions will be considered in the order received. A moderator will identify relevant questions and pose them to the panel of NNI agency representatives. Due to time constraints, not all questions may be addressed. The moderator reserves the right to group similar questions and to skip questions, as appropriate.

    FOR FURTHER INFORMATION CONTACT: Dr. Tarek Fadel, 703-292-7926, tfadel@nnco.nano.gov.

    http://www.gpo.gov/fdsys/pkg/FR-2014-07-22/html/2014-17189.htm

back to Federal Register Resource

Bookmark and Share


Trending News

Latest Twitter

Newsletter

Subscribe to our newsletter, sent out every month.